The Nasdaq fell just shy of an official "correction" between mid-March and mid-April, losing 9.8% of its value during that time frame. Even if that threshold wasn't reached, a number of stocks fell by large margins. When that happens, it's best to have a list of stocks to watch.
The Motley Fool's Brian Stoffel wants to let you know about one stock that's on his list: Catamaran (NASDAQ:CTRX). The company's stock hasn't been spared from the recent "correction," with shares trading about 25% lower than their 2014 highs. But Brian thinks there are three big reasons it's worth looking into this health-care stock now before others realize the value right before their eyes.
Invest in the next wave of health-care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion-dollar industry." And the technology behind it is poised to set off one of the most remarkable health-care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential and its ability to make life-changing medical solutions never thought possible. To learn how you can invest in this unbelievable new technology, click here now to see our free report.
Brian Stoffel has no position in any stocks mentioned. The Motley Fool recommends CVS Caremark. It recommends and owns shares of Catamaran and Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.